raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:686468

Post 5-alpha-reductase inhibitors treatment syndrome

Type
Disease
Group
Disorder
Inheritance
Not applicable
Status
active

A rare neurologic disease characterized by persistent side effects of terminated 5-alpha-reductase inhibitor treatment, including impaired sexual function (low libido, erectile dysfunction, diminished semen volume and force), genital numbness or paresthesia, gynecomastia, depression, brain fog and elevated anxiety. Additional symptoms may include muscular problems (tics, muscle spasms, tremors, involuntary muscle contraction and muscular ache), joint pain, chronic fatigue, migraine, decreased body temperature and dry skin.

1

Names in Orphadata languages

9 of 12 languages
LangNameSynonyms
enPost 5-alpha-reductase inhibitors treatment syndrome
frSyndrome post-traitement par inhibiteurs de la 5-alpha-reductase
dePost-5-alpha-Reduktase-Inhibitor-Syndrom
esSíndrome post-tratamiento con inhibidores de la 5-alfa-reductasa
itSindrome post trattamento con gli inibitori della 5-alfa-reduttasi
nlSyndroom na behandeling met 5-alfa-reductaseremmers
ptSíndrome pós-tratamento com inibidores da 5-alfa-redutase
plPost 5-alpha-reductase inhibitors treatment syndrome
csSyndrom po léčbě inhibitory 5-alfa-reduktázy

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10F52.8NTBTattributednot yet validated
MONDO975897Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

0 records

No prevalence record in this release.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card